Mark Applefeld
Cardiovascular Disease · Baltimore, MDNPI 1124060215
Payments from drug & device makers
Across 181 payments — averaging $20.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$743
- Amarin Pharma, Inc.$543
- Abbott$333
- Kowa Pharmaceuticals America, Inc.$316
- AstraZeneca$242
- Johnson & Johnson$175
- plus $1K from 17 others
What the payments were for
- Consulting fees$261%
- Food & beverage$3,58599%
- Education$251%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 45 | $743 |
| Amarin Pharma, Inc. | 26 | $543 |
| Abbott | 11 | $333 |
| Kowa Pharmaceuticals America, Inc. | 13 | $316 |
| AstraZeneca | 14 | $242 |
| Johnson & Johnson | 10 | $175 |
| Boehringer Ingelheim | 6 | $171 |
| Sanofi-aventis U.S. LLC | 9 | $165 |
| Cook Medical LLC | 5 | $151 |
| Amgen | 6 | $148 |
| Atricure, Inc. | 5 | $116 |
| E.r. Squibb & Sons, L.L.C. | 7 | $102 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 5 | $87 |
| Merck | 3 | $50 |
| Astellas Pharma US Inc | 2 | $48 |
| Irhythm Technologies, Inc. | 3 | $45 |
| Pfizer | 3 | $42 |
| Regeneron Healthcare Solutions, Inc. | 3 | $39 |
| Baxter Healthcare | 1 | $37 |
| Z-medica, LLC | 1 | $26 |
| Biotronik Inc. | 1 | $25 |
| Ultragenyx Pharmaceutical Inc. | 1 | $17 |
| Preventice Services, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,636 in reported general payments places this provider in the 60th percentile of 507 cardiovascular disease providers in Maryland.
Other cardiovascular disease in Baltimore
- Christopher DefilippiBaltimore$9.2M
- Thorsten LeuckerBaltimore$7.1M
- Joao LimaBaltimore$5.6M
- Jeffrey ColeBaltimore$4.8M
- Carlos InceBaltimore$3M
- Paul GurbelBaltimore$2.6M
- Navin KapurBaltimore$1.8M
- Robert WeissBaltimore$1.4M
- Stephen GottliebBaltimore$1.4M
- Jesse DoranBaltimore$1.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.